Caleb Ashbrook
Papers
2
Total Citations
41
H-Index
2
About
Caleb Ashbrook is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes and cost-effectiveness in urologic oncology and benign prostatic hyperplasia (BPH). His major contributions center on comparative effectiveness research, particularly evaluating robotic versus open surgical approaches. In his 2020 study on retroperitoneal lymph node dissection for germ cell tumors (22 citations), Ashbrook demonstrated that robotic surgery offers comparable perioperative outcomes to open surgery, with significant cost savings—a critical finding for testicular cancer care. That same year, his analysis of simple prostatectomy for BPH (19 citations) used the National Inpatient Sample to show that robot-assisted simple prostatectomy (RASP) reduces complications and hospital costs compared to open surgery, providing high-level evidence for adopting minimally invasive techniques in large prostates. Ashbrook’s work has helped define the value proposition of robotic surgery, balancing clinical outcomes with economic realities. His research is widely cited by urologists and health policy researchers seeking to improve surgical quality while managing healthcare costs.
Research Focus
Key Achievements
Top Papers
- 1
- 2